DUPONT CAPITAL MANAGEMENT CORP - SAGENT PHARMACEUTICALS INC ownership

SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 128 filers reported holding SAGENT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of SAGENT PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$332,000
-36.9%
21,6520.0%0.01%
-27.3%
Q2 2015$526,000
-49.4%
21,652
-47.7%
0.01%
-42.1%
Q4 2014$1,040,000
+15.3%
41,400
+7.2%
0.02%
+26.7%
Q1 2014$902,000
-54.3%
38,602
-50.4%
0.02%
-55.9%
Q4 2013$1,975,000
+7.7%
77,819
-13.4%
0.03%0.0%
Q3 2013$1,833,00089,8730.03%
Other shareholders
SAGENT PHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 453,392$11,022,0001.89%
GREAT POINT PARTNERS LLC 141,900$3,450,0001.34%
Penn Capital Management Company, LLC 1,247,428$30,325,0001.25%
Ranger Investment Management 982,240$23,878,0001.16%
HealthCor Management, L.P. 912,381$22,180,0001.12%
Piermont Capital Management Inc. 138,380$3,364,0001.02%
JW Asset Management, LLC 111,630$2,714,0000.82%
SECTORAL ASSET MANAGEMENT INC 465,625$11,319,0000.47%
ACUTA CAPITAL PARTNERS, LLC 28,000$681,0000.42%
Tekla Capital Management LLC 409,500$9,955,0000.36%
View complete list of SAGENT PHARMACEUTICALS INC shareholders